Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Laboratory, Cellular and Molecular Determinants of Clinical Success of the Treatment in Diabetic Patients With Critical Limb Ischemia (ECAD-CLI) Study

NCT03636867 is registered in ClinicalTrials.gov with Maria Cecilia Hospital as lead sponsor.

NCT NCT03636867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03636867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Laboratory, Cellular and Molecular Determinants of Clinical Success of the Treatment in Diabetic Patients With Critical Limb Ischemia (ECAD-CLI) Study
Lead sponsor
Maria Cecilia Hospital
Phase
Observational
Overall status
Completed
Start date
August 7, 2018
Completion date
August 31, 2020
Enrollment
236 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia, critical lower limb ischemia, diabetes mellitus, diabetic foot